Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory macrophages (Mregs) are a subset of macrophages with potent immunoregulatory properties. They are characterized by high IL-10 production, variable TGF-β production, and low IL-12 production. Mregs are induced by dual stimulation with a TLR ligand (e.g., LPS) and a secondary signal (e.g., PGE₂). They suppress inflammation, promote tolerance, and can be used therapeutically for autoimmune diseases and transplant rejection, but their immunosuppressive nature presents infection risks.
Macrophage polarization towards an anti-inflammatory and tolerogenic phenotype, suppressing pro-inflammatory cytokine production (IL-1β, IL-6, TNFα) and promoting Treg expansion via TGF-β secretion.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory Macrophage (Mreg).